1-3 of 3
Joelle Guilhot, MSci
Close
Sort by
Journal Articles

Outcome and Prognosis of 1955 Patients with Chronic Myeloid Leukemia: First Results of the CML-Registry of the European Treatment and Outcome Study EUTOS.

Joerg Hasford, MD, Gianantonio Rosti, MD, Doris Lindoerfer, Dipl.-Inf., Michele Baccarani, MD, Joelle Guilhot, MSci, Lara Montrucchio, Francesca Rancati, PhD, Bengt Simonsson, MD, Franck Emmanuel Nicolini, MD, PhD, Gert Ossenkoppele, MD, Ruediger Hehlmann, MD
Journal: Blood
Blood (2009) 114 (22): 1109.
https://doi.org/10.1182/blood.V114.22.1109.1109
Published: 2009
Journal Articles

Significant Higher Rates of Undetectable Molecular Residual Disease and Molecular Responses with Pegylated Form of Interferon a2a in Combination with Imatinib (IM) for the Treatment of Newly Diagnosed Chronic Phase (CP) Chronic Myeloid Leukaemia (CML) Patients (pts): Confirmatory Results at 18 Months of Part 1 of the Spirit Phase III Randomized Trial of the French CML Group (FI LMC).

François Guilhot, MD, Claude Preudhomme, Joelle Guilhot, MSci, Francois-Xavier Mahon, MD, PhD, Franck Emmanuel Nicolini, MD, PhD, Francoise Rigual-Huguet, MD, Laurence Legros, MD, PhD, Agnès Guerci, MD, PhD, Delphine Rea, MD, PhD, Valerie Coiteux, MD, Frederic Maloisel, MD, Martine Gardembas, MD, Claude-Eric Bulabois, MD, Marc G Berger, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 340.
https://doi.org/10.1182/blood.V114.22.340.340
Published: 2009
Journal Articles

Randomized Comparison of Imatinib Versus Imatinib Combination Therapies in Newly Diagnosed Chronic Myeloid Leukaemia (CML) Patients in Chronic Phase (CP): First Results of the Phase III (SPIRIT) Trial from the French CML Group (FI LMC)

Francois Guilhot, MD, François-Xavier Mahon, MD, PhD, Joelle Guilhot, MSci, Francoise Rigual-Huguet, MD, Frederic Maloisel, MD, Philippe Rousselot, MD, PhD, Martine Gardembas, MD, Selim Corm, MD, Agnes Guerci, MD, PhD, Anne Vekhoff, MD, Gabriel Etienne, MD, Laurence Legros, MD, Jean- Jacques Kiladjian, MD, PhD, Eric Jourdan, Michele Schoenwald, MD, Marc Berger, MD, Virginie Eclache, MD, Catherine Roche-Lestienne, PhD, Franck E Nicolini, MD, PhD, Claude Preudhomme, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 183.
https://doi.org/10.1182/blood.V112.11.183.183
Published: 2008